| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  PepKon PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families Type: | 9 | 6 | 6 | 7 |
 |  Myotact Innovation for patient autonomy Myotact is a medical device that detects muscle activity by EMG and translates it into virtual movement with vibrotactile feedback. Type: | 23 | 5 | 22 | 1 |
 | BariaTek BariaTek is a clinical stage company dedicated to treating obesity via a reversible non-invasive endoscopic approach. BariaTek Medical is a clinical stage company dedicated to addressing obesity via minimally invasive endoscopic approaches. Obesity is one of the most debilitating pandemics affecting humanity: More than 2 billion people are overweight of which 1 billion suffer from obesity. People suffering from obesity tend to lead shorter, less healthy, lives. Treating overweight-related conditions (diabetes, hypertension, sleep apnea and others) is projected to cost G-20 nations on average 8.7% of their health budgets over the next three decades which is estimated by the United … Type: | 1 | 0 | 1 | 18 |
 | The RFT Group #engineering #pharmajobs #medicaldevicesjobs #qualityassurance #regulatoryaffairs #drugdevelopment #clinicalresearch The RFT Group: Pharmaceutical, Biopharmaceutical & Medical Device Recruiting The RFT Group has an unrivalled track record in recruiting for our clients throughout Ireland Europe and the rest of the world. We are privileged Preferred Suppliers in recruiting for leading companies who have; jobs in Biopharmaceutical, Medical Devices, Engineering, Supply Chain, Pharmaceutical, Clinical Research, Commercialisation, Research & Development, Finance, HR and Jobs in pharmaceutical multinational corporations. We recruit across all levels from new graduate to CEO, and across all functions Medical Device, Biotechnology, Biologics, Clinical Research, QP, Regulatory Affairs, Commercialisation, Drug development, Human … Type: | 0 | 0 | 0 | 32 |
 | Sky Medical Technology Sky Medical develops bioelectronic devices to treat a wide range of acute and chronic circulatory conditions. Sky Medical develops bioelectronic devices integrated with OnPulse neuromodulation technology to prevent and treat a wide range of acute and chronic circulatory conditions (e.g. to prevent venous thromboembolism (VTE), to prevention and reduction of edema after surgery, to heal venous and arterial leg ulcers as well as chronic wounds, and speed-up recovery time for high-performance athletes. After conducting further clinical research, OnPulse is now being used in hospitals and in community care centers to accelerate patient recovery after surgery and to accelerate healing of … Type: | 0 | 0 | 0 | 7 |
 | Spring Branch Community Health Center Healthy Families. Healthy Community. Spring Branch Community Health Center is a private, non-profit community health center providing quality and affordable healthcare services to the underserved community of Spring Branch. Our mission is to provide comprehensive health services to all patients. Family Medicine, Women's Health, Dentist, Medical Clinic, Pediatrics, Laboratory, OB/GYN, Health Education, Ultrasounds, and Vaccinations Type: | 4 | 1 | 3 | 115 |
 | Dermatoo [Automatic translation follows] Dermatoo is a company aiming to provide digital solutions to prevent the deterioration of the general condition of complex wounds. e-health, wound management, medical device, and telemedicine Type: | 1 | 1 | 1 | 8 |
 | CFA Leem Apprentissage [Automatic translation follows] Becoming a professional in the health industries through apprenticeship: an opportunity to seize 🔬 CFA Leem Apprenticeship: Apprenticeship training for the health industries 🔬 🎓 Mission: To train students in specific professions in the health industries, particularly in research and development, production, marketing, and cross-disciplinary sectors such as quality assurance. 📚 More than 120 training courses throughout France in the following fields: - Regulatory Affairs - Food & Health - Quality Assurance - Biotechnologies & Biotherapies - Quality Control - Cosmetics - Medical Devices - Management and Innovation - Market Access - Marketing & Sales - Production … Type: | 14 | 2 | 10 | 21 |
 | DENTAURUM Ceramics [Automatic translation follows] Dentaurum Ceramics is one of the few companies in the world with specific knowledge in the design and manufacture of dental ceramics. The specialists in Angers have more than 30 years of experience in the manufacture of glass ceramics in powder and paste form dedicated to digital technologies. Dentaurum Ceramics has developed in the past and continues to develop outstanding technologies related to dental ceramics. Since 1994, Dentaurum Ceramics has been part of Dentaurum, a manufacturer of quality dental products with over 650 employees worldwide through its 8 subsidiaries. Dentaurum Ceramics is one of the few companies … Type: | 1 | 1 | 0 | 9 |
 | ISOSTEM Innovating Biologics ISOSTEM is a medical devices company based out of TEMIS CENTER 1 17 F RUE ALAIN SAVARY, BESANCON, France. Type: | 0 | 0 | 0 | N/A |
 | VISUfarma - the eye health company Creating value in eye health for our patients worldwide VISUfarma is a pan-European ophthalmic pharmaceutical company with a clear mission: to bring quality products and global therapeutic innovation to European eye health. We are an ambitious and fast growing ophthalmology company, commercializing a broad portfolio of pharmaceutical products and medical devices across Europe. (www.VISUfarma.com). The company was formed in 2016 and is the result of the successful combination of the Italian company Visufarma SpA and the commercial activities of the international Nicox SA, headquartered in France. The combination created VISUfarma. We offer a complete portfolio of products in the areas … Type: | 0 | 0 | 0 | 98 |
 | LUMICKS Empowering scientists with tools that reveal crucial insights not available before, at the molecular and cellular level. LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human … Type: | 5 | 2 | 3 | 173 |
 | MedApp Nederland [Automatic translation follows] MedApp. The smart pharmacy. For a healthcare professional, the importance of adequate medication adherence is no secret. Unfortunately, around forty percent of patients fail to consistently administer medication. There are more than three hundred underlying causes, many of which can be classified as procrastination, forgetfulness or insufficient stock. MedApp gives medication users control over medication by offering a solution that actually works. Moreover, MedApp goes beyond the medication user by linking to the professional healthcare world. By registering medication intake, a healthcare provider can easily gain insight into the intake behavior within the population and a pharmacist … Type: | 1 | 0 | 1 | 67 |
 | Citryll Translating NET biology into novel therapies for inflammatory diseases Citryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases. With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached the clinic by demonstrating a precise and powerful ability to control NETs and NETosis. Citryll is initially developing CIT-013 as a novel drug for rheumatoid arthritis and hidradenitis suppurativa, which may serve as enabling indications for a wide spectrum of inflammatory diseases. The initial clinical trials with CIT-013 are expected to … Type: | 0 | 0 | 0 | 25 |
 | Meatable We're pioneering a way to produce real, tasty meat without harming animals or the planet. It isn’t like meat, it is meat Meatable makes 100% real, delicious, guilt-free meat. With one cell, we are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time we increase food security, without compromising the culinary experience of eating tasty, real meat. cultivated meat Type: | 6 | 5 | 2 | 133 |
 | Magnosco GmbH Magnosco GmbH, founded in 2014, is a MedTec Company based in the technology park Berlin-Adlershof. We offer a non-invasive method supporting (early) detection of malignant melanoma based on laser technology. CEO Inga Bergen and COO Thomas Diepold lead the team of scientist and technical experts. Magnosco cooperates with Charité Berlin, University Hospital of Tübingen and the University Hospital of Heidelberg, hospital operator Vivantes and LTB Lasertechnik Berlin regarding the development and certification as a medical device. More and more people know that if skin lesions are changing a doctor’s expertise is very important to detect skin cancer early on. Especially … Type: | 0 | 0 | 0 | 15 |
 | PreOmics SETTING THE STANDARD FOR PROTEIN ANALYSIS PreOmics empowers its clients in life sciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis. Our team spirit, energy, and commitment empower us to be both creative and quality-focused – A trusted partner with deeply rooted scientific experience.We envisage a future with revolutionary proteomic discovery processes open for everyone. Tools that reveal hidden causes of diseases, ensure sustainable nutrition, and provide diagnoses that enhance lives and society. PreOmics GmbH Am Klopferspitz 19 82152 Planegg/Martinsried Germany Contacts: Telephone: +49-89-2314163-0 Telefax: +49-89-2314163-99 Email: info@preomics.com Privacy Policy: https://www.preomics.com/legal/data-privacy-policy … Type: | 1 | 0 | 1 | 60 |
 | NUMAFERM Biomade Peptides We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production. Type: | 3 | 1 | 3 | 16 |
 | Immunic Therapeutics Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/ Type: | 3 | 0 | 3 | 84 |
 | Noscendo GmbH Using #NGS of cell free nucleic acids to identify over a thousand microbes we change the way #pathogens are identified Noscendo GmbH, a Duisburg (Germany) based molecular diagnostics company, changes the way infection causative microbes are identified. Introducing a paradigm shift using proprietary algorithms and software harnessing next generation sequencing of cell free nucleic acids isolated from patient samples Noscendo brings the concept of liquid biopsy into the field of infectious diseases. Noscendo’ s software solution is capable of differentiating infection from non-infectious signals and thereby aiding intensive care clinicians in their daily task to find the right decisions, enabling … Type: | 1 | 1 | 0 | 47 |
 |  Belyntic GmbH The Precision Vaccines Company Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity. Drug development, Cellular immunity, and Platform technology Type: | 1 | 0 | 0 | 2 |
 | IRUBIS Innovative Process Analytical Spectroscopy for Upstream and Downstream Processing IRUBIS | Innovative Process Analytical Spectroscopy for Biomanufacturing. IRUBIS is a company that specializes in mid-infrared (MIR) spectroscopy for bioprocessing. We have designed an instrument, Monipa, specifically for bioprocess monitoring and control. Monipa is based on MIR spectroscopy, making it possible to monitor multiple bioprocesses real-time and continuously. Our instrument's applications are foreseen in both upstream and downstream bioprocessing. These include multiple metabolite monitoring and control in upstream processing. In addition, contaminant detection or monitoring of target proteins and excipients can be aided in downstream processing. Read more about our products … Type: | 6 | 0 | 3 | 18 |
 | Angiolutions We turn science into medicine. Angiolutions – breaking new ground in abdominal aortic aneurysm (AAA) treatment. Abdominal aortic aneurysms are threatening the lives of millions of patients around the world with no way to intercept early disease progression. Angiolutions will change that. Angiolutions is the first company to develop a therapeutic device preventing disease progression in small abdominal aortic aneurysms. Type: | 1 | 0 | 1 | 9 |
 |  TetraKit Technologies Next Generation Theranostics TetraKit Technologies (2021) is a spin-off company originating from the University of Copenhagen (KU). Our mission is to revolutionize theranostic agent development through our unique chemistry - The TetraKit Platform. It allows for one-fits-all radiolabeling of most targeting vectors with optimal diagnostic and therapeutic radionuclides. We develop both, our core platform technology, as well as proprietary novel theranostic radiopharmaceuticals based on our platform. This technology is based on the latest advancements in click chemistry and radiolabeling techniques coming from our laboratories. We are interested in partnerships to combine our radiolabeling platform with emerging targeting vectors. Radiopharmaceuticals, Nuclear … Type: | 1 | 1 | 0 | 99 |
 | Rebiotix Inc (a Ferring Company) A Ferring Company working to harness the power of the human microbiome to address unmet medical needs. Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com. Biotechnology, Microbiome, Drug Development, Medicine, Clinical Trials, Regulatory Innovation, Patient Support, Internal Medicine, Manufacturing, Infectious Disease, Gastroenterology, Emerging Diseases, and Novel Technology Type: | 0 | 0 | 0 | 90 |
 | Karyopharm Therapeutics Inc. Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with high unmet need. Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL). oncology, pharmaceutical, biotech, … Type: | 6 | 0 | 1 | 387 |
 | Nanna Therapeutics Totally Integrated Medicines Engine (TIME) to Cure Diseases Type: | 0 | 0 | 0 | N/A |
 | Oncoheroes Biosciences A Biotech Company 100% Focused On Advancing New Therapies For Childhood Cancer A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer Type: | 4 | 0 | 2 | 12 |
 | Vicore Pharma AB Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. AlmeeTM (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. … Type: | 1 | 0 | 0 | 40 |
 | PhoreMost Ltd Drugging the Undruggable® PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®’ disease targets using our next-generation technology, SITESEEKER®. Using PROTEINi® libraries, this unique drug target identification platform can discern the best new targets for future therapy and crucially, how to drug them, which has the potential to significantly increase the diversity and affordability of novel therapeutics for cancer and other unmet diseases. PhoreMost is building a pipeline of novel drug discovery programmes aimed at addressing a range of diseases, with a mission to accelerate, diversify and rationalise drug discovery. Using … Type: | 5 | 0 | 2 | 54 |
 | DACER Rehabilitación Funcional daño cerebral [Automatic translation follows] Where there is a dream...there is a way DACER Functional Rehabilitation is a non-profit organization specializing in the rehabilitation of patients with brain damage, whether congenital or acquired. We know and experience Brain Damage as something of our own. More than 80% of the shares are from members with affected families. Its founding members are neurological physiotherapists, occupational therapists, speech therapists, neuropsychologists and neuro-rehabilitation physicians. It has the technical and business support of its president and its engineering and new technology companies - Quálitas and CBM Management-. Our reason for being encompasses all activities related to the … Type: | 0 | 0 | 0 | 39 |
 | Trutino Biosciences ON DEMAND CYTOKINE Company Trutino means ‘Balance’ in Latin, and this represents our strategy, namely an Rx/Dx approach for Precision Oncology Drug & Clinical Development. The company logo symbolizes well balanced wings. As it takes both wings to fly, we believe a balanced Rx/Dx drug development will ultimately deliver on the promise of Precision Oncology. Our effort focuses on ‘targeted destruction of cancer cells’ and simultaneous ‘differential activation of tumor-specific immune cells’ to maximize treatment response. ON DEMAND CYTOKINE, CYTOKINE DRUG, IMMUNO-ONCOLOGY, and TARGETED ONCOLOGY Type: | 0 | 0 | 0 | 16 |
 | Enterprise Therapeutics Dedicated to the development of novel therapies to improve the lives of patients with respiratory disease Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. … Type: | 1 | 1 | 1 | 13 |
 | Biognosys Transforming life sciences with cutting-edge proteomics technology and solutions The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. Our Solutions We offer a versatile portfolio of proprietary proteomics services, software, and kits. We make these widely available for pharmaceutical and biotechnology researchers and proteomics experts. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all major sample types – cells, tissues, or body fluids – across human … Type: | 4 | 0 | 4 | 91 |
 | T3 Pharmaceuticals AG Developing the next generation bacterial cancer therapy Developing the next generation bacterial cancer therapy The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria. T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein … Type: | 1 | 1 | 0 | 24 |
 | BiomX Inc Customized phage therapies to eradicate harmful bacteria in chronic diseases BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. Microbiome, Biotechnology, Drug Discovery, and Phage Therapies Type: | 1 | 0 | 1 | 70 |
 | Cognito Therapeutics, Inc. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT. Type: | 8 | 0 | 3 | 50 |
 | Kymera Therapeutics Inventing a new class of medicines using Targeted Protein Degradation Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged … Type: | 3 | 0 | 2 | 205 |
 | SOLNATIDE project H2020 project exploring safety, tolerability and clinical efficacy of solnatide IMP in COVID-19 patients. The SOLNATIDE project will clinically test the safety, tolerability and clinical efficacy of solnatide IMP in patients with severe COVID-19 requiring mechanical ventilation. APEPTICO’s lead-compound solnatide IMP has been designed for the therapeutic treatment of patients with Acute Respiratory Distress Syndrome (ARDS) and various forms of Pulmonary Oedema (PPO). Orally inhaled solnatide has delivered clinical proof-of-concept in one Phase I and two Phase IIa clinical studies (EUDRACT No. 2011-000223-33, 2012-001863-64 and 2013-000716-21). Currently, solnatide is subject to a Phase IIB trial (EUDRACT No. 2017-003855-47) being approved … Type: | 0 | 0 | 0 | N/A |
 | Proxygen The Art of Glue Hunting A curious team of explorers, deeply rooted in science, and constantly on the lookout for a very particular novel drug modality. This is us – Proxygen. We hunt for glue degraders. They are the key to unlocking new treatments for patients. They revolutionize how we see and cure diseases. Type: | 1 | 0 | 0 | 39 |
 | OXGENE A WuXi Advanced Therapies company, based in Oxford, UK. OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENETM is headquartered in Oxford, UK. For additional information, please visit our website. PRODUCTS: Largest collection of standardised plasmids on the market and SERVICES: DNA Services, Protein Production Services, Virus Services, Cell Line Development Services. Type: | 4 | 0 | 0 | 57 |
 | ASCIL Biopharm We make injectable products better Ascil Biopharm is a Drug Delivery System company specialized in Long Acting Injectables (LAI) and devices. Our Research and development is focused in Controlled Release Formulations (CRF) and precision medical devices to enhance efficiency, safety, and patient convenience. Controlled Release Formulations, Long Acting Injectables, Drug Delivery Systems, and Parenteral Type: | 0 | 0 | 0 | 28 |
 | Enara Bio Advancing cancer immunotherapy by targeting the unconventional Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneering EDAPT® platform enables us to discover novel cancer-specific antigens from previously uncharted genomic ‘dark matter’. The result is a growing database of Dark Antigens that can address the unmet need for cancer-specific targets that are homogenously expressed and highly prevalent in solid tumors. We are advancing multiple approaches to exploit these Dark Antigen targets, with an internal focus on TCR-directed immunotherapies, and additional therapeutic … Type: | 8 | 1 | 4 | 63 |
 | Axonis Therapeutics Axonis Therapeutics is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibition within the brain, by translating breakthrough discoveries spun out from Boston Children’s Hospital, Harvard and Laval University. We are an exceptional team of drug hunters and target biology experts who have built a proprietary KCC2 discovery engine based on several years of world-leading know-how, to become the leaders in this potential blockbuster drug space. A venBio portfolio company, Axonis has raised $34+M in dilutive Seed funding, and … Type: | 8 | 1 | 3 | 20 |
 | Gubra Science of certainty Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across … Type: | 2 | 0 | 2 | 260 |
 | G1 Therapeutics, Inc. Our mission is to discover, develop and deliver next generation cancer therapies. G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos. Cancer / Oncology, Drug Discovery and Development, and Biotechnology Type: | 1 | 0 | 0 | 71 |
 | Biome Diagnostics Advancing cancer care through microbiome profiling 🦠 Discover your microbiome: www.mybioma.com Biome Diagnostics GmbH (BiomeDx®) is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop first in class technologies for routine clinical practice. Additionally to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on the development of medically certified products in the area of gut microbiome and cancer. As safety and health of patients are top priorities, the company has … Type: | 6 | 1 | 3 | 20 |
 | Delta4ai Delta4 is a Vienna-based biotech startup driving the forefront of digital drug discovery and development. Delta4 is driving the forefront of digital drug discovery and development. We leverage a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs. Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effects. drug repositioning, drug discovery, compounds, orphan diseases, indication expansion, AI, and omics Type: | 4 | 0 | 0 | 11 |
 | a:head bio AG we aim to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of … Type: | 2 | 0 | 1 | 18 |
 | Nanoform Global experts in nanotechnology and drug particle engineering Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Type: | 12 | 0 | 4 | 163 |
 | Enanta Pharmaceuticals Our vision is to transform the lives of patients with curative therapies. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for virology and immunology indications. Enanta’s research and development programs are currently focused on respiratory syncytial virus (RSV) and chronic spontaneous urticaria (CSU) and the company has previously advanced clinical-stage compounds for SARS-CoV-2 (COVID-19) and chronic hepatitis B virus (HBV) infection. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) … Type: | 2 | 0 | 2 | 161 |
 | Terns Pharmaceuticals Taking the Journey Towards Comprehensive Treatment of Serious Disease Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated … Type: | 0 | 0 | 0 | 64 |
 | Sixfold Bioscience RNA delivery, evolved. RNA delivery, evolved. Drug delivery, RNA, and RNA delivery Type: | 7 | 1 | 5 | 24 |
 | Karuna Therapeutics Pushing the boundaries of neuroscience to transform the treatment of mental illness. Karuna Therapeutics, Inc. is now part of Bristol Myers Squibb. Learn about how we are continuing to transform the lives of patients with neurological and neuropsychiatric diseases @Bristol Myers Squibb or www.bms.com. Type: | 5 | 1 | 4 | 118 |
 | InterAx Biotech Advanced integration of biological systems, math models and artificial intelligence The company, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerland, uses high throughput biochemical screening of compounds integrated into an artificial intelligence and cell pathways mathematical modeling process. This platform unlocks previously intractable targets, shortens timelines for drug discovery from years to months and reduces risks. The company focuses on the generation and optimization of drugs which trigger a specific and well characterized effect on signaling pathways, thus leading to higher therapeutic efficacy and reduced risk of toxicity. The company is specialized in GPCR drug discovery and … Type: | 4 | 0 | 3 | 17 |
 | DeNovix Inc. We design, manufacture and sell award-winning lab equipment for today's life scientists. DeNovix Inc., founded in 2012, is a Wilmington, DE, USA based instrumentation company that develops, manufactures and sells laboratory equipment to meet the demands of today’s evolving life science research. DeNovix focuses on providing innovative products and outstanding customer support. The company is equipped with the financial, commercial and technical resources to deliver breakthrough products for research success. DeNovix products include the DS-11 Series Spectrophotometer / Fluorometer, the CellDrop Automated Cell Counter, the QFX Fluorometer and DeNovix assays. Our instruments are stand-alone (no PC needed) and built on … Type: | 2 | 0 | 1 | 27 |
 | PHC Corporation of North America Life Science Innovator Since 1966 PHC Corporation of North America (PHCNA) is headquartered in Wood Dale, IL and manufactures and markets PHCbi brand laboratory equipment. PHCNA is a subsidiary of PHC Holdings Corporation of Tokyo, Japan, a global diversified life sciences, diagnostics, and medical device company. For more than 50 years, PHCNA has met the needs of pharmaceutical, biotechnology, hospital/clinical, and industrial customers, offering a unique perspective on scientific research. We play a critical role in global product development across a range of research areas and have a deeply entrenched reputation as a manufacturer of highly-reliable quality and innovative laboratory … Type: | 5 | 0 | 1 | 203 |
 | invIOs INNOVATIVE IMMUNO-ONCOLOGY Developing tomorrow's cancer therapies. Today. invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials. We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics. Our highly motivated team of 35 people has deep expertise across the … Type: | 1 | 0 | 0 | 24 |
 | Eveliqure Biotechnologies Eveliqure Biotechnologies is developing novel vaccines for the prevention of diarrhoeal diseases. Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries. Eveliqure is a game-changer amongst vaccine companies, championing novel technologies to make the world safe from diarrhoea. Eveliqure is passionate about improving the quality of life for both the poor and the privileged by providing innovative medical solutions that fight diarrhoeal diseases. Type: | 2 | 0 | 1 | 6 |
 | QUANTRO Therapeutics GmbH Discovery and development of novel therapeutics targeting transcription factors in cancer and other diseases QUANTRO Therapeutics (“QUANTRO”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. QUANTRO will assemble a highly innovative drug-discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. The first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. QUANTRO was founded as a spin-off of the Institute of Molecular Biotechnology (“IMBA”) and the Research Institute … Type: | 1 | 0 | 1 | 14 |
 | Surrozen Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway. Surrozen was founded by five leading-edge scientists: K. Christopher Garcia, Ph.D., Roel Nusse, Ph.D. and Calvin Kuo, M.D., Ph.D. from Stanford University; Claudia Janda, Ph.D. from the Princess Maxima Center for Pediatric Oncology; and Hans Clevers, M.D, Ph.D. from the Hubrecht Institute and Princess Maxima Center. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen’s technology and approach to therapeutic development. The … Type: | 1 | 1 | 1 | 72 |
 | Hervolution Therapeutics Therapeutics for the Disease of Aging Immune therapy platform targeting Dark Genome antigens that contribute to aging, cancer, diabetes, and neurodegenerative diseases Oncology, Aging, Dark Genome, ALS, Diabetes, and Longevity Type: | 2 | 0 | 1 | 20 |
 | Mosa Meat Pioneering a cleaner, kinder way of making beef. In 2013, our Chief Scientific Officer Professor Mark Post unveiled the world’s first cultured meat hamburger to a packed press conference in London. The burger was harvested directly from cow cells, rather than raising and slaughtering a whole animal. It was the result of years of research at Maastricht University, and cost €250,000 to make. The effort was funded by Sergey Brin, the co-founder of Google. Our motivation was to find a new method to make real meat to feed our fast-growing population in a sustainable, healthy and animal-friendly way. Following the … Type: | 13 | 8 | 6 | 131 |
 | ALPX Automated protein crystallography for faster new structures and expert small molecule screening. All our services include access to fully automated, remote-controlled protein-to-structure pipelines based on the innovative technologies CrystalDirectTM and CRIMS developed at EMBL. Type: | 2 | 2 | 0 | 17 |
 | RonomA [Automatic translation follows] Providing patients with neurodegenerative diseases with a new, innovative therapeutic approach Type: | 4 | 1 | 3 | 3 |
 | ExoAtlet It all begins with the first step ExoAtlet is an international company that develops and produces wearable exoskeletons – devices on the convergence of robotics and biomechatronics that augment human ability to perform different actions and tasks in a variety of medical and industrial scenarios in China, Europe, Japan, South Korea and the USA. We are architects of the technology-driven ecosystem for ExoRehabilitation in Asia and Europe. We provide recovery devices, i.e. wearable exoskeletons for children and adults, and assistive robotic tools for industry workers and elderly people. We synergise with the European research centres in our mutual mission to … Type: | 1 | 1 | 0 | 19 |
 | Adcytherix Targeted Cancer Therapies Adcytherix BV is a biotech company focused on the development of antibody drug conjugates for high unmet need diseases such as cancer. ADC and oncology Type: | 0 | 0 | 0 | 6 |
 | ArkAb ArkAb is now Bcell Design! ArkAb is now Bcell Design! Bcell Design develops and manufactures chimeric monoclonal antibodies with human-like characteristics for in vitro diagnostics. We provide a secure and reliable source of raw material as a best alternative to disease state plasma and human serum, currently used as calibrators, positive controls or quality controls. Through its technological platform, built upon 15 years’ expertise in mAb and early-stage immunotherapy development, IVD developers and manufacturers gain access to a wide range of antibodies that are immediately ready for testing in human models. Founded in 2007 and from one of the few … Type: | 0 | 0 | 0 | 1 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 11 | 10 | 1 | 48 |
 | Cellforcure a NOVARTIS company CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an … Type: | 2 | 2 | 0 | 104 |
 | Sunogel Inc Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration. Type: | 0 | 0 | 0 | 1 |
 | UMR Right We are an immunology lab pursuing innovative ways to control cancer as well as inflammation in diseases and graft. UMR Right is a joint research unit affiliated to INSERM (National Institute of Health and Medical Research), EFS (French Blood Bank Institute) and the University of Franche-Comté. We develop basic, translational and clinical research programs to improve knowledge, diagnosis and treatments in the context of cancer immunity and immunotherapy (Team: TIMC), and organ and cell transplantation, inflammatory and autoimmune diseases (Team: ATI). Our main goals: - Characterize the pathogenic or protective immune responses involved in these diseases in order to identify … Type: | 7 | 3 | 1 | 35 |
 | Inside Tx Revolutionizing nanoparticle and RNA-LNP formulation with innovative microfluidic-based systems! At InsideTX, we are revolutionizing nanoparticle manufacturing, to unlock the full potential of RNA-LNP therapeutics and nanomedicines. At the convergence of microfluidics and biotechnology, we strive to provide laboratories, biotech, and pharma companies with the ultimate nanoparticle synthesis capabilities by solving three of the biggest challenges of the RNA-LNP revolution: Easing screeening, ensuring seamless scalability all along the development process and allowing for continuous production. Leveraging our patented technology, our complementary team is developping the only end-to-end nanoparticle synthesis platform that accelerates your screening to production time while improving your probability … Type: | 19 | 6 | 9 | 12 |
 | ENDODIAG Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients worldwide!). Located in Evry, France, within Genopole, the French largest Biocluster, the company leverages the experience of its scientific cofounders who have been working in this field for over 20 years and a network of major hospital centres both in France and abroad. Although endometriosis is a major cause of subfertility (40% of affected patients are infertile) and chronic pain, it takes … Type: | 8 | 6 | 0 | 6 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 44 | 16 | 31 | 183 |
 | PathoQuest A global CRO providing NGS-based Quality Control testing for rapid and safe release of biotherapies to patients. PathoQuest is a global CRO providing NGS-based Quality Control testing through its iDTECT® platform of assays for rapid and safe release of biotherapies to patients. Validated and accepted GMP assays for viral safety and genetic characterization of raw materials, cell and gene therapies, mAbs & vaccines. Testing available in Paris (France) and in Wayne PA. Biologics Testing, Biosafety Testing, Biologics Quality Testing, Biologics QC based on Next Generation Sequencing (NGS), Viral Safety, Genetic Characterization, Testing for Clone selection, Genetic Stability Testing, Release Testing … Type: | 1 | 0 | 1 | 55 |
 | AXELIFE [Automatic translation follows] Expertise - Prevention - Innovation Axelife is a 100% French Medtech company specializing in the field of cardiovascular risk assessment and prevention. We design and develop assessment and prevention solutions, our first medical device: the pOpmètre, measures the Gold Standard pulse wave velocity for measuring arterial stiffness. The MD is class IIa and the company is ISO 13485. Our scientific team is working on algorithms to calculate arterial age and has participated in the publication of more than 30 scientific publications that have supported the interest in measuring arterial stiffness. Type: | 44 | 8 | 14 | 14 |
 | POLYVALAN Proteins Structures Got Easier With Crystallophores Emerged from academic research, POLYVALAN (IBS & ENS Lyon Spin-off company) is a young innovative company founded in December 2016 dedicated to structural biology. POLYVALAN competitive edge is its unique chemical approach allowing significant gain of effectiveness, time and/or precision for protein structure determination that allows an optimal use of the existing large equipments. structural biology, protein crystallization, crystallization screening, nucleating agent, phasing agent, crystallophore, structure determination, X-ray crystallography, and drug design Type: | 2 | 1 | 0 | 3 |
 | NMR - Bio Your partner for innovation NMR-Bio is a CRO located in Grenoble (France), one of the most vibrant European hubs for structural biology and supplies compounds for the selective labelling of methyl groups in perdeuterated proteins. NMR-Bio also offers a broad range of services for NMR applications: - Custom labelled protein production in bacteria, cell-free system, insect cells, HEK293 and CHO cells - Solution for labelling of your biopharmaceutics especially mAbs and Fabs - High-field NMR data acquisition and analysis (e.g. quality control, spectra assignment, structure calculation, dynamic characterisation). Type: | 1 | 1 | 0 | 2 |
 | Biossan your partner for preclinical research Biossan : A French CRO dedicated to biomedical research Biossan helps its academic and industrial partners develop their innovations by performing preclinical trials under controlled conditions. Biossan specializes in evaluating medical devices, new techniques, and pharmaceutical products in healthy and pathological models. Conduite et accompagnement de projet de recherche, Organisation de formation, and Bien-être et expérimentation animale Type: | 1 | 1 | 0 | 1 |
 | Athana® [Automatic translation follows] Relief of hot flashes by cryotherapy Athana is a French start-up specializing in the commercialization of innovative solutions for women's natural well-being, particularly for those suffering from the effects of menopause. We focus on improving quality of life by offering natural and effective alternatives to hormonal treatments, which are often associated with health risks. Our mission is to alleviate hot flashes, the most debilitating symptom of menopause, affecting 900 million women worldwide. To address this need, we have developed two flagship products: Héra, a portable device that uses cryotherapy to provide instant relief from hot flashes, and … Type: | 11 | 3 | 6 | 8 |
 | IMD-Pharma SAS Rebalancing the immune system, resolving inflammation. Drug candidates from our molecular platforms normalize the immune system by downregulating pro-inflammatory immune response and upregulating regulatory immune response. IMD-Pharma S.A.S is a french biotechnology company conducting research and development of innovative drug candidates for immune-related inflammatory diseases. Founded in 2016, IMD-Pharma is a company from the Laboratoire de Chimie de Coordination (CNRS) and the Centre de Physiopathologie de Toulouse Purpan (INSERM/CNRS/Université Toulouse III). immuno-modulation, anti-inflammatory drugs, chronic inflammatory diseases, Multiple Sclerosis, Rheumatoid Arthritis, dendrimers, monocyte rehabilitation, and psoriasis Type: | 1 | 0 | 1 | 7 |
 | MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 36 | 14 | 31 | 81 |
 | iThylo iThylo supports companies on all alcohol issues : prevention, screening, follow-up iThylo is the first connected ethylotest. For professionals, it allows companies to ensure that their employees are able to work in the best possible conditions. The iThylo team's mission is to manage risks in companies. To contact us hello@ithylo.com Informatique, Objets connectés, Securité, Prévention, Pilotage des risques, Ethylotest connecté, Accompagnement, medtech, Dispositifs Médicaux connectés, dépistage, alcool, alcohol, drogue, and drug Type: | 7 | 2 | 5 | 22 |
 | CrannMed CrannMed is developing resorbable embolization technologies CrannMed was founded in 2018 with the aim of bringing together world-leading clinical, material science and delivery system experts to deliver the benefits of resorbable embolisation to patients worldwide. Permanent microspheres have existed for more than 20 years, and are routinely used to treat liver cancer, uterine fibroids and benign prostate hyperplasia. Resorbable microspheres can be used to treat a range of new indications where it is desirable to restore blood flow to the targeted area after the desired therapeutic effect has been achieved. These resorbable microspheres have new applications in areas such as … Type: | 0 | 0 | 0 | 15 |
 | Seed Therapeutics Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.” Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success. Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients. Biotechnology, Biotherapeutics, Cell … Type: | 10 | 1 | 9 | 16 |
 | Schrödinger Transforming drug discovery and materials research Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com. Type: | 2 | 2 | 0 | 966 |
 | EPSMR [Automatic translation follows] Public Mental Health Establishment of Reunion. Ansanm sa minm nout shömin! The Public Mental Health Establishment of Reunion provides prevention, hospitalization and follow-up after hospitalization for patients in the North, West and East health territories of the department (population of the basin concerned: more than 540,000 inhabitants). It has 532 beds and places spread over two full-time hospitalization sites (Grand Pourpier and Bras Fusil) and around forty other structures including: - 14 day hospitals, - 15 Medico-Psychological Centers, - 3 Part-Time Therapeutic Reception Centers, - 2 Psychiatric Reception Units in general hospitals - 2 Short-Term Hospitalization Units, … Type: | 3 | 1 | 2 | 329 |
 | Sangamo Therapeutics, Inc. We're committed to translating our ground-breaking science into genomic medicines that transform patients’ lives. For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, … Type: | 8 | 0 | 4 | 300 |
 | Logos Biosystems See beyond your cells. Advanced imaging solutions for research excellence. Logos Biosystems is the life science solutions of Aligned Genetics, Inc., dedicated to the development and commercialization of innovative technologies to support the life science research community. Since its founding in 2008, Logos Biosystems has been developing a series of automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis. Type: | 4 | 0 | 1 | 26 |
 | String Bio Private Limited String Bio enables Next Generation Ingredients that are sustainable and traceable for evolving value chains. String’s purpose is to commercialize next generation ingredients that enable sustainability and traceability in evolving value chains. String Bio is in the business of manufacturing raw materials for Animal Nutrition, Agriculture, Human Nutrition and Personal Care sectors that are derived using a sustainable and traceable process. String, as one of the world leaders in gas fermentation, has a strong IP protected platform called SIMP (String Integrated Methane Platform) that enables production of high quality ingredients using methane. Our proprietary platform leverages advances in synthetic biology, … Type: | 3 | 1 | 2 | 83 |
 | Neuron Guard THE NEW STANDARD OF CARE FOR THE TARGETED TEMPERATURE MANAGEMENT OF PATIENTS Neuron Guard is an Italian medical device company that has developed a technology to deliver hot and cold therapy for body surfaces. One application is for selective brain temperature management. Other treatment options are focused on the need for local cooling or heating of body surfaces. The company was formally founded in 2013 for the development of portable non invasive cooling and warming systems. Our product CB240_Aurora is a portable hot or cold therapy system composed by a collar/wrap powered by a smart control unit. In 2022 CB240_Aurora … Type: | 7 | 2 | 2 | 3 |
 | GreenBone Ortho Innovation to enhance bone healing. Our mission is to advance the science of bone regeneration through cutting-edge research and continuous innovation by partnering with researchers and physicians. We provide patients with safe, effective products that treat bone defects and promote healing. Bone regeneration, Orthopaedics, Traumatology, Bone substitute, Innovation, Bone void, Biomimetic and Bioactive bone substitute , and Medical Device Type: | 15 | 6 | 0 | 29 |
 | TENSIVE SRL Advanced Biomaterials for Regenerative Medicine Tensive is a biomedical company developing advanced biomaterials for regenerative medicine applications, with a current focus on reconstructive surgery after breast cancer. Type: | 0 | 0 | 0 | 24 |
 | Amber Therapeutics Doing the extraordinary to restore the ordinary Amber Therapeutics was founded in 2021 with a mission to develop and deliver breakthrough neuromodulation therapies that can fundamentally transform outcomes in areas of unmet clinical need. With the acquisition of Finetech Medical Limited and Bioinduction Ltd in 2023, we are continuing to be the only UK based company in the field of designing and manufacturing long-term implantables. We have since grown into a multidisciplinary team, combining deep medical device experience with a culture and mindset focused on transformational innovation. Amber UI is the company’s first therapy, aiming to restore normal physiological function … Type: | 2 | 2 | 0 | 33 |
 | Hilleman Laboratories Pvt. Ltd. HILLEMAN LABORATORIES IS COMMITTED TO DEVELOPING HIGH IMPACT, AFFORDABLE VACCINES FOR PEOPLE IN DEVELOPING COUNTRIES. A first-of-its-kind initiative, Hilleman Laboratories is an equal joint-venture partnership formed between Merck & Co., a global research-driven pharmaceutical company and Wellcome Trust, a global charitable foundation dedicated to human and animal health. Headquartered in India, Hilleman Laboratories is a not-for-profit organization leveraging a cadre of talented scientists from around the globe. The MSD Wellcome Trust Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner. The work of the Hilleman Laboratories will focus … Type: | 2 | 0 | 2 | 10 |
 | RGL Research Supporting Healthcare Innovation R.G.L Research is a contract research organization (CRO) providing expertise and reliable support to the pharmaceutical industries for conducting Clinical Trials. Our clients and partners include pharmaceuticals, biotechnologies, startups, academic and government organization. R.G.L Research is providing tailored and quality services to help clients and partners bend the cost and time curve of drug development to deliver new alternative product and innovative treatment to improve patients quality of life. R.G.L Research has vast professional experience and academic knowledge in performing clinical trials in Israel as well as developing health product in diverse therapeutic areas of medicine, in … Type: | 2 | 1 | 1 | 0 |
 | HargolTM FoodTech Hargol FoodTech, Delivering Better Protein! Healthier and more sustainable complete protein. HargolTM FoodTech, delivering better protein. Healthier and more sustainable complete protein. #ClimateAction #PlanetBasedProtein #CompleteProtein For more information contact: Dror Levy, CEO dror.levy@hargol.com +972-54-762-5508 Protein, Insects, Farming, Africa, Sustainable, Ingredient, Food, Food security, Healthy food, feed, omega 3, grasshoppers, agriculture, agritech, foodtech, amino acids, bugs, Edible Insects, Grasshopper, Innovation, Food Security, Complete Protein, and Planet Based Protein Type: | 5 | 2 | 2 | 8 |
 | Vectorious Medical Technologies The world's first in-heart microcomputer for heart failure management Vectorious Medical Technologies develops novel treatment for heart failure patients which is based on physician directed, patients’ self-management paradigm. Leveraging its advanced, first of its kind, implantable V-LAP platform, which harvests valuable information from the heart’s left atrium, physicians and patients can monitor and manage disease status, prevent hospitalizations and improve quality of life. The V-LAP system is an investigational device which is currently under evaluation in multiple clinical studies in Europe, Israel and the U.S. Medical Devices, Wireless communication, Miniature Implants, Heart Failure, Remote Monitoring, and Sensors Type: | 0 | 0 | 0 | 89 |
 | Aleph Farms We design new ways to grow animal products, starting with Aleph CutsTM, our new take on steak. Aleph Farms®, an Israel-based cellular agriculture company, enhances sustainability, food security and animal welfare by diversifying the supply and decentralizing the production of quality animal proteins and fats as a complement to sustainable methods of conventional animal agriculture. Founded in 2017, the company unveiled the world’s first cultivated thin-cut beef steak in 2018, the world’s first cultivated ribeye steak in 2021, and cultivated collagen in 2022. Under its product brand, Aleph CutsTM, the company is launching its first product, the cultivated Petit Steak, … Type: | 22 | 7 | 12 | 102 |
Startup